Short Description
Quantifies glycogen content by converting it to glucose.
Development Stage
Research-Grade Metabolic Assay Development
Description
The OXPHOSight™ Glycogen Assay Kit assesses tissue energy reserves, which is critical for evaluating the pharmacodynamics of insulin analogs and glycogen storage disease therapies. Its quantitative lysis-to-detection workflow simplifies the measurement of hepatic and muscle glycogen levels in metabolic disease models. This tool provides vital data on energy homeostasis and the effectiveness of pharmacological interventions in diabetes research.
Features
Quantitative lysis-to-detection workflow; Assessing hepatic and muscle energy storage in metabolic disease models and athletic performance research.
Process Relevance
Metabolic Disease Efficacy Testing
Application Stage
Pre-clinical Efficacy
Applications
Monitors energy storage in tissue homogenates.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 570 nm, or Fluorescence Detection (Ex 530 nm / Em 585 nm)
Sample Type
Serum, citrate-plasma, urine, cell lysate, culture medium
Research Areas
Diabetes & Obesity; Hepatology
Datasheet